ArticleScience translational medicine2021

The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C.

John V Pluvinage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.